Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:42 PM
Ignite Modification Date:
2025-12-24 @ 9:42 PM
NCT ID:
NCT03110432
Eligibility Criteria:
Inclusion Criteria:
* • with familial, homozygous hypercholesterolemia, in whom pharmaceutical and diet options for lipid lowering have proved insufficient, or
* with confirmed familial, heterozygous hypercholesterolemia under consideration of the total familial risk, or
* with heterozygous familial or non- familial hypercholesterolemia or mixed dyslipidemia with
* therapy refractory course
* maximal dietary and pharmaceutical lipid lowering therapy - in any case documented over a 12-month period
* unsatisfactorily lowered LDL-C value (and thus with an indication for LDL apheresis)
* confirmed vascular disease
* other risk factors for cardiovascular events
Exclusion Criteria:
* Concurrent participation of the patient in a clinical randomised study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT03110432
Study Brief:
Protocol Section:
NCT03110432